Our Team

Our Team

Julius Goepp

Chief Science Office (CSO)

Julius Goepp is the Co-Founder and CSO of Evimero, LLC, a pre-clinical stage biotech company focused on passive immunotherapy in the microbiome. His patented technology is developed around the modulation of the microbiome through the use of little-known avian antibodies, or IgY. His research is focused on exploring the characteristics of those antibodies and developing a drug discovery platform based on their use as selective immunomodulators of complex microbiome signaling pathways and event cascades